The researchers at Johns Hopkins University believe that the foot pump will be superior to
      sequential compression devices in comfort and patient compliance which may increase provider
      efforts to prevent deep vein thrombosis (DVT) in pregnancy.

A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population

Thrombophilia

The investigators will be comparing sequential compression devices (SCDs) to foot pumps to
      determine if foot pumps will be better tolerated by obstetric patients, both antepartum and
      intrapartum. Patients in whom thromboembolic prophylaxis is deemed necessary and ordered by
      the treating physician, who agree to participate in the study will be randomly assigned to
      receive SCDs or the foot pump as part of their thromboembolic prophylaxis regimen. The
      investigators will administer a questionnaire to assess patients' satisfaction and comfort
      with each device and they will be asked to complete a log of hours they wore their assigned
      device for a 7 day period (or as long as they are prescribed). Random spot checks to verify
      compliance will be performed.

Kendall A-V foot impulse pump, model 6060

Kendall sequential compression device, model 9525

Study of Patient Compliance and Comfort Using Sequential Compression Devices and Foot Pumps for DVT Prevention

Scale of 1-10 (1 being very uncomfortable and 10 being very uncomfortable) describing level of comfort during the time of device use (composite score of heat, softness, discomfort).

Nurse conducting random checks throughout hospital stay and events of noncompliance will be recorded

Patients will have the Kendall, A-V foot impulse pump, model 6060 applied to their lower extremities to prevent DVT

Patients will have the Kendall,sequential compression device, model 9525 applied to the lower extremities to prevent DVT

A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Trial Timing

What is this trial about?

What are the participation requirements?